메뉴 건너뛰기




Volumn 97, Issue 5, 2001, Pages 1227-1231

Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; HLA ANTIGEN; PREDNISONE; THYMOCYTE ANTIBODY;

EID: 0035283077     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.5.1227     Document Type: Article
Times cited : (509)

References (35)
  • 11
  • 33
    • 0027323727 scopus 로고
    • Busulfan disposition: The role of therapeutic monitoring in bone marrow transplantation induction regimens
    • (1993) Semin Oncol , vol.20 , pp. 18-25
    • Growchow, L.B.1
  • 34
    • 0021826986 scopus 로고
    • Pretransplant condition with busulfan (Myleran) and cyclophosphamide for nonmalignant diseases: Assessment of engraftment following histocompatible allogeneic bone marrow transplantation
    • (1985) Transplantation , vol.9 , pp. 597-603
    • Blazar, B.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.